Posted by Michael Wonder on 11 Jul 2019
Reforming the Orphan Drug Act for the 21st century
11 July 2019 - The pharmaceutical market has undergone radical changes, including markedly increased prices for rare-disease drugs.
The revenue generated by such products raises questions about whether the Orphan Drug Act should be reformed to better align with the needs of patients.
